Home Medicine Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty
Article
Licensed
Unlicensed Requires Authentication

Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty

  • Margarita Raygada EMAIL logo , Kathryn S. King , Karen T. Adams , Constantine A. Stratakis and Karel Pacak
Published/Copyright: May 22, 2014
Journal of Pediatric Endocrinology and Metabolism
From the journal Journal of Pediatric Endocrinology and Metabolism Volume 27 Issue 9-10

Abstract

The discovery that mutations in the succinate dehydrogenase (SDH) complex subunit (SDHA, B/C/D/AF2) genes predispose patients to the development of tumors has led to the identification of a large population of patients and relatives at risk for developing malignancies. The most frequent conditions associated with these mutations are the familial paraganglioma syndromes. Other tumors that are frequently associated with SDH mutations (SDHx) are gastrointestinal stromal tumors and renal cell carcinomas. A number of other rare associations have also been described. SDHx mutations are often clinically silent and metastatic, but they may also be aggressive in their presentation. The penetrance of these mutations is beginning to be understood, and the characteristics of the phenotype are being elucidated. However, the inability to accurately predict the appearance, nature, and location of tumors as well as their tendency to recur or metastasize pose challenges to those who counsel and manage patients with SDHx mutations. In this work, we present our approach for counseling these families in the context of the current uncertainties, while striving to maintain patient autonomy.

Keywords: counseling; paragangliomas; pheochromocytoma; subunits; succinate dehydrogenase
Corresponding author: Margarita Raygada, Eunice Kennedy Shriver National Institute of Child Health and Human Development Section on Developmental Genetics, 10 Center Dr MSC 1831, Room # 10D36A, Bethesda, MD 20892-1831, USA, Phone: +(301)451-8822, Fax: +(301)480-7557, E-mail:

Acknowledgments

This work was funded by the Intramural Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Conflict of interest statement: The authors declared no conflict of interest.

References

1. Raygada M, Pasini B, Stratakis CA. Hereditary paragangliomas. Adv Otorhinolaryngol 2011;70:99–106.10.1159/000322484Search in Google Scholar

2. Winship T, Kloop CT, Jenkins WH. Glomus jugularis tumors. Cancer 1948;1:441.10.1002/1097-0142(194809)1:3<441::AID-CNCR2820010310>3.0.CO;2-ISearch in Google Scholar

3. Beard CM, Sheps SG, Kurland LT, Kurland LT, Carney JA, et al. Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 1983;58:802–4.Search in Google Scholar

4. Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001;69:49–54.10.1086/321282Search in Google Scholar

5. Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000;287:848–51.10.1126/science.287.5454.848Search in Google Scholar

6. Burnichon N, Briere JJ, Libé R, Vescovo L, Rivière J, et al. SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet 2010;19:3011–20.10.1093/hmg/ddq206Search in Google Scholar

7. Hao HX, Khalimonchuk O, Schraders M, Dephoure N, Bayley JP, et al. SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 2009;28:1139–42.10.1126/science.1175689Search in Google Scholar

8. Niemann S, Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 2000;26:268–70.10.1038/81551Search in Google Scholar

9. Qin Y, Yao L, King EE, Buddavarapu K, Lenci RE, et al. Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat Genet 2010;42:229–33.10.1038/ng.533Search in Google Scholar

10. Comino-Méndez I, Gracia-Aznárez FJ, Schiavi F, Landa I, Leandro-GarcÃa LJ, et al. Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat Genet 2011;43:663–7.10.1038/ng.861Search in Google Scholar

11. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002;346:1459–66.10.1056/NEJMoa020152Search in Google Scholar

12. Baysal BE, Farr JE, Rubinstein WS, Galus RA, Johnson KA, et al. Fine mapping of an imprinted gene for familial nonchromaffin paragangliomas, on chromosome 11q23. Am J Hum Genet 1997;60:121–32.Search in Google Scholar

13. Mariman EC, van Beersum SE, Cremers CW, van Baars FM, Ropers HH. Analysis of a second family with hereditary non-chromaffin paragangliomas locates the underlying gene at the proximal region of chromosome 11q. Hum Genet 1993;91:357–61.10.1007/BF00217356Search in Google Scholar

14. Heutink P, van Schothorst EM, van der Mey AG, Bardoel A, Breedveld G, et al. Further localization of the gene for hereditary paragangliomas and evidence for linkage in unrelated families. Eur J Hum Genet 1994;2:148–58.10.1159/000472358Search in Google Scholar

15. Milunsky J, DeStefano AL, Huang XL, Baldwin CT, Michels VV, et al. Familial paragangliomas: linkage to chromosome 11q23 and clinical implications. Am J Med Genet 1997;72:66–70.10.1002/(SICI)1096-8628(19971003)72:1<66::AID-AJMG14>3.0.CO;2-SSearch in Google Scholar

16. Mariman EC, van Beersum SE, Cremers CW, Struycken PM, Ropers HH. Fine mapping of a putatively imprinted gene for familial non-chromaffin paragangliomas to chromosome 11q13.1: evidence for genetic heterogeneity. Hum Genet 1995;95:56–62.10.1007/BF00225075Search in Google Scholar

17. Niemann S, Becker-Follmann J, Nürnberg G, Rüschendorf F, Sieweke N, et al. Assignment of PGL3 to chromosome 1 (q21–q23) in a family with autosomal dominant non-chromaffin paraganglioma. Am J Med Genet 2001;98:32–6.10.1002/1096-8628(20010101)98:1<32::AID-AJMG1004>3.0.CO;2-8Search in Google Scholar

18. Sato T, Saito H, Yoshinaga K, Shibota Y, Sasano N. Concurrence of carotid body tumor and pheochromocytoma. Cancer 1974;34:1787–95.10.1002/1097-0142(197411)34:5<1787::AID-CNCR2820340529>3.0.CO;2-7Search in Google Scholar

19. van der Mey AG, Maaswinkel-Mooy PD, Cornelisse CJ, Schmidt PH, van de Kamp JJ. Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory. Lancet 1989;2:1291–4.10.1016/S0140-6736(89)91908-9Search in Google Scholar

20. Armstrong R, Greenhalgh KL, Rattenberry E, Judd B, Shukla R, et al. Succinate dehydrogenase subunit B (SDHB) gene deletion associated with a composite paraganglioma/neuroblastoma. J Med Genet 2009;46:215–6.10.1136/jmg.2008.060749Search in Google Scholar

21. Janeway KA, Kim SY, Lodish M, Nosé V, Rustin P, et al. Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations. Proc Natl Acad Sci USA 2010 4;108:314–8.10.1073/pnas.1009199108Search in Google Scholar

22. Ricketts C, Woodward ER, Killick P, Morris MR, Astuti D, et al. Germline SDHB mutations and familial renal cell carcinoma. J Natl Cancer Inst 2008;100:1260–2.10.1093/jnci/djn254Search in Google Scholar

23. Vanharanta S, Buchta M, McWhinney SR, Virta SK, Peçzkowska M, et al. Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. Am J Hum Genet 2004;74:153–9.10.1086/381054Search in Google Scholar PubMed PubMed Central

24. Burnichon N, Rohmer V, Amar L, Herman P, Leboulleux S, et al. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. J Clin Endocrinol Metab 2009;94:2817–27.10.1210/jc.2008-2504Search in Google Scholar PubMed

25. Pasini B, Stratakis CA. SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes. J Intern Med 2009;266:19–42.10.1111/j.1365-2796.2009.02111.xSearch in Google Scholar PubMed PubMed Central

26. Karasek D, Frysak Z, Pacak K. Genetic testing for pheochromocytoma. Curr Hypertens Resp 2010;12:456–64.10.1007/s11906-010-0151-1Search in Google Scholar PubMed PubMed Central

27. Baysal BE. Clinical and molecular progress in hereditary paraganglioma. J Med Genet 2008;45:689–94.10.1136/jmg.2008.058560Search in Google Scholar PubMed

28. Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, et al. European-American Paraganglioma Study Group 2004 Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. J Am Med Assoc 2004;292:943–51.10.1001/jama.292.8.943Search in Google Scholar PubMed

29. Ni Y, He X, Chen J, Moline J, Mester J, et al. Germline SDHx variants modify breast and thyroid cancer risks in Cowdenand Cowden-like syndrome via FAD/NAD-dependant destabilization of p53. Hum Mol Genet 2012;21:300–10.10.1093/hmg/ddr459Search in Google Scholar PubMed PubMed Central

30. Ni Y, Zbuk KM, Sadler T, Patocs A, Lobo G, et al. Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes. Am J Hum Genet 2008;83:261–8.10.1016/j.ajhg.2008.07.011Search in Google Scholar PubMed PubMed Central

31. Schimke RN, Collins DL, Stolle CA. Paraganglioma, neuroblastoma, and a SDHB mutation: resolution of a 30-year-old mystery. Am J Med Genet 2010;152A;1531–5.10.1002/ajmg.a.33384Search in Google Scholar PubMed

32. Bardella C, Pollard PJ, Tomlinson I. SDH mutations in Cancer. Biochim Biophys Acta 2011;1807:1432–43.10.1016/j.bbabio.2011.07.003Search in Google Scholar PubMed

33. Benn DE, Gimenez-Roqueplo AP, Reilly JR, Bertherat J, Burgess J, et al. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab 2006;91:827–36.10.1210/jc.2005-1862Search in Google Scholar PubMed

34. Eisenhofer G, Lenders JW, Siegert G, Bornstein SR, Friberg P, et al. Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. Eur J Cancer 2011;48:1739–49.10.1016/j.ejca.2011.07.016Search in Google Scholar PubMed PubMed Central

35. Eisenhofer G, Lenders JW, Timmers H, Mannelli M, Grebe SK, et al. Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clin Chem 2011;57:411–20.10.1373/clinchem.2010.153320Search in Google Scholar PubMed PubMed Central

36. Prodanov T, Havekes B, Nathanson KL, Adams KT, Pacak K. Malignant paraganglioma associated with succinate dehydrogenase subunit B in an 8-year-old child: the age of first screening? Pediatr Nephrol 2009;24:1239–42.10.1007/s00467-008-1111-8Search in Google Scholar PubMed PubMed Central

37. Algeciras-Schimnich A, Preissner CM, Young WF Jr, Singh RJ, Grebe SK. Plasma chromogranin A or urine fractionated metanephrines follow-up testing improves the diagnostic accuracy of plasma fractionated metanephrines for pheochromocytoma. J Clin Endocrinol Metab 2008;93:91–5.10.1210/jc.2007-1354Search in Google Scholar PubMed PubMed Central

38. Hoegerle S, Ghanem N, Altehoefer C, Schipper J, Brink I, et al. 18F-DOPA positron emission tomography for the detection of glomus tumours. Eur J Nucl Med Mol Imaging 2003;30:689–94.10.1007/s00259-003-1115-3Search in Google Scholar PubMed

39. King KS, Chen CC, Alexopoulos DK, Whatley MA, Reynolds JC, et al. Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy. J Clin Endocrinol Metab 2011;96:2779–85.10.1210/jc.2011-0333Search in Google Scholar PubMed PubMed Central

40. King KS, Whatley MA, Alexopoulos DK, Reynolds JC, Chen CC, et al. The use of functional imaging in a patient with head and neck paragangliomas. J Clin Endocrinol Metab 2010;95:481–2.10.1210/jc.2009-2214Search in Google Scholar PubMed PubMed Central

41. Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, et al. Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 2009;94:4757–67.10.1210/jc.2009-1248Search in Google Scholar PubMed PubMed Central

42. Solanki KK, Bomanji J, Moyes J, Mather SJ, Trainer PJ, et al. A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). Nucl Med Commun 1992;13:513–21.10.1097/00006231-199207000-00006Search in Google Scholar PubMed

43. King KS, Prodanov T, Kantorovich V, Fojo T, Hewitt JK, et al. Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations. J Clin Oncol 2011;29:4137–42.10.1200/JCO.2011.34.6353Search in Google Scholar PubMed PubMed Central

Received: 2013-9-13
Accepted: 2014-3-14
Published Online: 2014-5-22
Published in Print: 2014-9-20

©2014 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Review article
  3. Towards an optimization of the management of endocrine complications of thalassemia
  4. Original articles
  5. The natural course of Hashimoto’s thyroiditis in children and adolescents
  6. Muscle strength and body composition during the transition phase in patients treated with recombinant GH to final height
  7. Benign vaginal bleeding in 24 prepubertal patients: clinical, biochemical and imaging features
  8. Evaluation of epicardial adipose tissue, carotid intima-media thickness and ventricular functions in obese children and adolescents
  9. Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty
  10. Pubertal development profile in patients with Turner syndrome
  11. A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder
  12. Serum insulin-like growth factor-binding protein-3 level correlated with glycemic control and lipid profiles in children and adolescents with type 1 diabetes
  13. Adult human liver mesenchymal progenitor cells express phenylalanine hydroxylase
  14. Clinical applicability of rapid detection of SRY and DYS14 genes in patients with disorders of sex development using an indigenously developed 5′ exonuclease based assay
  15. Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia in four Egyptian families: report of three novel mutations in the vitamin D receptor gene
  16. Permanent neonatal diabetes mellitus in Jordan
  17. The effect of adenotonsilectomy on ghrelin, leptin, IGF-1 levels and growth parameters in children with adenotonsillar hypertrophy
  18. The role of anti-Mullerian and inhibin B hormones in the evaluation of 46,XY disorders of sex development
  19. The evaluation of thyroid carcinoma in childhood and concomitance of autoimmune thyroid disorders
  20. Lipid patterns in treated growth hormone deficient children vs. short stature controls
  21. Assessment of aortic morphology and compliance in children and adolescents with Ullrich-Turner syndrome (UTS) using magnetic resonance imaging (MRI)
  22. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants
  23. Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone
  24. Patient reports
  25. A rare case of pituitary infarction leading to spontaneous tumour resolution and CSF-sella syndrome in an 11-year-old girl and a review of the paediatric literature
  26. Rare case of homozygous epimerase deficiency and heterozygous of duarte 2 variant
  27. Persistent congenital hyperinsulinism in two patients with Beckwith-Wiedemann syndrome due to mosaic uniparental disomy 11p
  28. Growth hormone treatment in a patient with Hurler-Scheie syndrome
  29. Neonatal diagnosis of a patient with hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR) syndrome associated with cerebral infarction
  30. Early-onset diabetes mellitus and neurodevelopmental retardation: the first Greek case of Wolcott-Rallison syndrome
  31. Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus
  32. Cushing’s syndrome: hidden risk in usage of topical corticosteroids
  33. Prader-Willi syndrome: a case report with atypical developmental features
  34. Berardinelli-Seip congenital lipodystrophy: an autosomal recessive disorder with rare association of duodenocolonic polyps
  35. Ectopic Cushing syndrome secondary to metastatic medullary thyroid cancer in a child with multiple endocrine neoplasia syndrome type 2B: clues to early diagnosis of the paraneoplastic syndromes
  36. Ovarian hyperstimulation syndrome treated by medroxyprogesterone acetate
  37. Symptomatic cerebral infarction in a child with severe diabetic ketoacidosis
  38. A rare case of familial Cushing’s syndrome with a common presentation of weight gain due to a mutation of the PRKAR1A gene causing isolated primary pigmented nodular adrenocortical disease
  39. Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: is there an association? A case report and literature review
  40. Cholestasis and protein-losing enteropathy secondary to hyperthyroidism in a 6-year-old girl
  41. Short communication
  42. An essential splice site mutation (c.317+1G>A) in the TSHR gene leads to severe thyroid dysgenesis
  43. Letter to the Editor
  44. Pubertal gynecomastia: what about the remaining 10%?
https://doi.org/10.1515/jpem-2013-0369
Keywords for this article
counseling; paragangliomas; pheochromocytoma; subunits; succinate dehydrogenase

Articles in the same Issue

  1. Frontmatter
  2. Review article
  3. Towards an optimization of the management of endocrine complications of thalassemia
  4. Original articles
  5. The natural course of Hashimoto’s thyroiditis in children and adolescents
  6. Muscle strength and body composition during the transition phase in patients treated with recombinant GH to final height
  7. Benign vaginal bleeding in 24 prepubertal patients: clinical, biochemical and imaging features
  8. Evaluation of epicardial adipose tissue, carotid intima-media thickness and ventricular functions in obese children and adolescents
  9. Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty
  10. Pubertal development profile in patients with Turner syndrome
  11. A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder
  12. Serum insulin-like growth factor-binding protein-3 level correlated with glycemic control and lipid profiles in children and adolescents with type 1 diabetes
  13. Adult human liver mesenchymal progenitor cells express phenylalanine hydroxylase
  14. Clinical applicability of rapid detection of SRY and DYS14 genes in patients with disorders of sex development using an indigenously developed 5′ exonuclease based assay
  15. Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia in four Egyptian families: report of three novel mutations in the vitamin D receptor gene
  16. Permanent neonatal diabetes mellitus in Jordan
  17. The effect of adenotonsilectomy on ghrelin, leptin, IGF-1 levels and growth parameters in children with adenotonsillar hypertrophy
  18. The role of anti-Mullerian and inhibin B hormones in the evaluation of 46,XY disorders of sex development
  19. The evaluation of thyroid carcinoma in childhood and concomitance of autoimmune thyroid disorders
  20. Lipid patterns in treated growth hormone deficient children vs. short stature controls
  21. Assessment of aortic morphology and compliance in children and adolescents with Ullrich-Turner syndrome (UTS) using magnetic resonance imaging (MRI)
  22. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants
  23. Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone
  24. Patient reports
  25. A rare case of pituitary infarction leading to spontaneous tumour resolution and CSF-sella syndrome in an 11-year-old girl and a review of the paediatric literature
  26. Rare case of homozygous epimerase deficiency and heterozygous of duarte 2 variant
  27. Persistent congenital hyperinsulinism in two patients with Beckwith-Wiedemann syndrome due to mosaic uniparental disomy 11p
  28. Growth hormone treatment in a patient with Hurler-Scheie syndrome
  29. Neonatal diagnosis of a patient with hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR) syndrome associated with cerebral infarction
  30. Early-onset diabetes mellitus and neurodevelopmental retardation: the first Greek case of Wolcott-Rallison syndrome
  31. Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus
  32. Cushing’s syndrome: hidden risk in usage of topical corticosteroids
  33. Prader-Willi syndrome: a case report with atypical developmental features
  34. Berardinelli-Seip congenital lipodystrophy: an autosomal recessive disorder with rare association of duodenocolonic polyps
  35. Ectopic Cushing syndrome secondary to metastatic medullary thyroid cancer in a child with multiple endocrine neoplasia syndrome type 2B: clues to early diagnosis of the paraneoplastic syndromes
  36. Ovarian hyperstimulation syndrome treated by medroxyprogesterone acetate
  37. Symptomatic cerebral infarction in a child with severe diabetic ketoacidosis
  38. A rare case of familial Cushing’s syndrome with a common presentation of weight gain due to a mutation of the PRKAR1A gene causing isolated primary pigmented nodular adrenocortical disease
  39. Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: is there an association? A case report and literature review
  40. Cholestasis and protein-losing enteropathy secondary to hyperthyroidism in a 6-year-old girl
  41. Short communication
  42. An essential splice site mutation (c.317+1G>A) in the TSHR gene leads to severe thyroid dysgenesis
  43. Letter to the Editor
  44. Pubertal gynecomastia: what about the remaining 10%?
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 6.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0369/html?lang=en
Scroll to top button